Antibodies against Toxoplasma gondii in patients with VIH in Yucatan;Anticuerpos contra Toxoplasma gondii en pacientes con VIH en Yucatán

Revista de Investigacion Clinica

Volumn 50, Issue 5, 1998, Pages 419-422

  Góngora Biachi, Renán A ^a   González Martínez, Pedro ^a   Castro Sansores, Carlos ^a   Alvarez Moguel, Rafael ^b   Pavía Ruz, Norma ^a   Lara Perera, Dora ^a   Alonzo Salomón, Gabriela ^a   Palacios Pérez, Elizabeth ^a  

^a UNIVERSIDAD AUTÓNOMA DE YUCATÁN   (Mexico)

^b SECRETARÍA DE SALUD   (Mexico)

Author keywords

AIDS; Antibodies IgG; Blood donors; Human immunodeficiency virus; Mexico; Toxoplasmosis

Indexed keywords

IMMUNOGLOBULIN G; PROTOZOON ANTIBODY;

AIDS RELATED COMPLEX; ANIMAL; ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MEXICO; PARASITOLOGY; PREVALENCE; TOXOPLASMA; TOXOPLASMOSIS; ZOONOSIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; ANTIBODIES, PROTOZOAN; HIV INFECTIONS; HUMANS; IMMUNOGLOBULIN G; MEXICO; PREVALENCE; TOXOPLASMA; TOXOPLASMOSIS; ZOONOSES;

EID: 0032152468     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Kasper LH. Toxoplasma infection. En: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martín JB, Kasper LH, Hauser SL, Longo DL, eds. Principles of internal medicine. Vol. 1. 14th ed. New York: McGraw-Hill; 1998:1197-202.
2. Grant IH, Gold JWM, Rosenblum M, Niedzwiecki D, Armstrong D. Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS. AIDS 1990; 4:519-21.
3. Dannemann BR, Israelki DM, Leoung GS, McGraw T, Mills J, Remington JS. Toxoplasma serology, parasitemia and antigenemia in patients at risk for toxoplasmic encephalitis. AIDS 1991; 5:1363-5.
4. Mastroianni CM, Liuzzi GM, Vullo SD, Riccio P. Demyelination and cerebral toxoplasmosis in HIV-infected patients. AIDS 1993; 7:745-6.
5. Ruiz-Palacios GM, Ponce de León S, Cruz-López A, Tinoco JC, Schneiders B, Macías A, et al. Características del síndrome de inmunodeficiencia adquirida en 93 pacientes del Instituto Nacional de la Nutrición Salvador Zubirán. Rev Invest Clin 1987; 39 (Suppl):7-12.
6. Volkow P, Ponce de Léon S, Calva J, Ruiz-Palacios G, Mohar A. Transfusion associated AIDS in Mexico. Clinical spectrum, conditional latency, distribution and suvirval. Rev Invest Clin 1993; 45:133-8.
7. Mohar A, Romo J, Salido F, Jessurum J, Ponce de León S, Reyes E, et al. The spectrum of clinical and pathological manifestations of AIDS in a consecutive series of autopsied patients in Mexico. AIDS 1992; 6:467-73.
8. Góngora-Biachi RA, González-Martínez P, Puerto FI. Clinical and epidemiological spectrum of AIDS in a group of patients in the Yucatan peninsula. Fourth International AIDS Symposium, San Juan, Puerto Rico, November 1991, p.28.
9. Guerrero-Flores A. Encefalitis toxoplásmica en el SIDA. Treinta y nueve casos clínicos. Enf Infec Microbiol 1997; 17:65.
10. Center for Diseases Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolecents and adults. MMWR 1992; 41:1-19.
11. Pelloux HJT, Derouin F, Ambroise T. Specific antitoxoplasmic immunoglobulin G detected by western blot in AIDS patients: relationship to visceral localization. AIDS 1992; 32:885-6.
12. Góngora-Biachi RA, González-Martínez P. Puerto-Manzano F, Castro-Sansores C. Inmunopatogénesis de la infección por el virus de la inmunodeficiencia humana. Rev Biomed 1991; 2:207-16.
13. Oksenhendler E, Charreau I, Tournerie C, Azihary M, Carbon C, Aboulker Jp. Toxoplasma gondii infection in advanced HIV infection. AIDS 1994; 8:483-7.
14. Harden CL, Hair LS. Diagnosis of central nervous system toxoplasmosis in AIDS patients confirmed by autopsy. AIDS 1994; 8:1188-9.
15. Ruf BHD, Schürmann D, Pohle H. Failure of clarithromycin in preventing toxoplasmic encephalitis in AIDS patients. J Acquir Immun Defic Synd 1992; 5:530-1.
16. Pedrol E, González-Clemente JM, Gatell JM, Mallolas J, Miró JM, Graus F, et al. Central nervous system toxoplasmosis in AIDS patients: efficacy of an intermittent maintenance therapy AIDS 1990; 4:511-7.
17. Jacobson MA, Besch CL, Child C, Hafner R, Matts JP, Muth, et al. Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients with advanced human immunodeficiency virus disease: results of a randomized trial. J Infect Dis 1994; 169:384-94.
18. Alder J, Hutch T, Meulbroeck JA, Clement JC. Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine. J Acquir Immun Defic Synd 1994; 7:1141-8.